Crowd-Sourced RNA Designs Outclass Computer Algorithms
|
By LabMedica International staff writers Posted on 05 Feb 2014 |

Image: RNA design produced by a player of the online EteRNA design game (Photo courtesy of Carnegie Mellon University).
An energetic group of nonexperts, working through an online interface and receiving feedback from lab experiments, has generated RNA (ribonucleic acid) molecule designs that are consistently more effective than those generated by the best computerized design algorithms.
Moreover, the researchers collected some of the best design rules and practices generated by players of the online EteRNA design challenge, and employing machine learning principles, generated their own automated design algorithm, EteRNABot, which also outperform earlier design algorithms. Although this optimized computer design application is faster than humans, the designs it generates still do not match the quality of those of the online community, which now has more than 130,000 members.
The research was published January 27, 2014, in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) online early edition. “The quality of the designs produced by the online EteRNA community is just amazing and far beyond what any of us anticipated when we began this project three years ago,” said Dr. Adrien Treiulle, an assistant professor of computer science and robotics at Carnegie Mellon University (Pittsburgh, PA, USA), who leads the project with Dr. Rhiju Das, an assistant professor of biochemistry at Stanford University (Stanford, CA, USA; www.stanford.edu), and Jeehyung Lee, a PhD student in computer science at Carnegie Mellon.
“This wouldn’t be possible if EteRNA members were just spitting out designs using online simulation tools,” Dr. Treuille continued. “By actually synthesizing the most promising designs in Das’ lab at Stanford, we’re giving our community feedback about what works and doesn’t work in the physical world. And, as a result, these nonexperts are providing us insight into RNA design that is significantly advancing the science.”
RNA is one of the three macromolecules vital for life, along with DNA and proteins. Long recognized as a messenger for genetic data, RNA also may play a much larger role as a regulator of cells. Understanding RNA design could be helpful for treating or controlling diseases such as HIV, for creating RNA-based sensors or even for building computers out of RNA.
The researchers, in the project, assessed the performance of the EteRNA community, EteRNABot and two cutting-edge RNA design algorithms in generating designs that would cause RNA strands to fold themselves into specific shapes. The computers could generate designs in less than one minute, while most people would take one or two days; synthesizing the molecules to determine the success and quality took a month for each design, so the entire experiment lasted about a year.
Ultimately, Dr. Lee reported, the designs produced by humans had a 99% likelihood of being superior to those of the earlier computer algorithms, whereas EteRNABot produced designs with a 95% probability of outdoing the earlier algorithms. “The quality of the community’s designs is so good that even if you generated thousands of designs with computer algorithms, you’d never find one as good as the community’s,” Mr. Lee said.
When the project began, players were asked to design RNA that folded into specific shapes selected by the Das lab. Due to technologic advances that now enable Dr. Das and his team to synthesize 1,000 design sequences monthly instead of the original 30, EteRNA has become an open research project to which researchers from labs around the world can submit design challenges.
Even though EteRNA players may not be scientifically trained, they nonetheless have instincts that, when reinforced by the lab experiments, can lead to new insights. “Most players didn’t have tactical insights on RNA designs,” Mr. Lee said. “They would just recognize patterns—visual patterns. Scientifically, not all of these rules initially seemed to make sense, but people who were following them did better.”
One design rule generated by the players involves “capping.” RNA consists of long sequences of pairs of nucleotides and typically the simplest way to create a sequence or “stack” that will not tear itself apart when synthesized is to fill it with guanine-cytosine (GC) pairs. However, too many GC pairs can generate some unforeseen shapes when synthesized, “It’s like doing origami with a cardboard box,” as one player noted.
According to Mr. Lee, the players found a solution by putting the GC pairs only at the end of the stack—capping—and filling the rest of the stack with adenine-uracil pairs. The investigators are now looking at expanding its design regimen to include three-dimensional (3D) designs. They also are developing a template that researchers in other fields can use to convert scientific projects into online challenges.
Related Links:
Carnegie Mellon University
Stanford University
EteRNA design challenge
Moreover, the researchers collected some of the best design rules and practices generated by players of the online EteRNA design challenge, and employing machine learning principles, generated their own automated design algorithm, EteRNABot, which also outperform earlier design algorithms. Although this optimized computer design application is faster than humans, the designs it generates still do not match the quality of those of the online community, which now has more than 130,000 members.
The research was published January 27, 2014, in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) online early edition. “The quality of the designs produced by the online EteRNA community is just amazing and far beyond what any of us anticipated when we began this project three years ago,” said Dr. Adrien Treiulle, an assistant professor of computer science and robotics at Carnegie Mellon University (Pittsburgh, PA, USA), who leads the project with Dr. Rhiju Das, an assistant professor of biochemistry at Stanford University (Stanford, CA, USA; www.stanford.edu), and Jeehyung Lee, a PhD student in computer science at Carnegie Mellon.
“This wouldn’t be possible if EteRNA members were just spitting out designs using online simulation tools,” Dr. Treuille continued. “By actually synthesizing the most promising designs in Das’ lab at Stanford, we’re giving our community feedback about what works and doesn’t work in the physical world. And, as a result, these nonexperts are providing us insight into RNA design that is significantly advancing the science.”
RNA is one of the three macromolecules vital for life, along with DNA and proteins. Long recognized as a messenger for genetic data, RNA also may play a much larger role as a regulator of cells. Understanding RNA design could be helpful for treating or controlling diseases such as HIV, for creating RNA-based sensors or even for building computers out of RNA.
The researchers, in the project, assessed the performance of the EteRNA community, EteRNABot and two cutting-edge RNA design algorithms in generating designs that would cause RNA strands to fold themselves into specific shapes. The computers could generate designs in less than one minute, while most people would take one or two days; synthesizing the molecules to determine the success and quality took a month for each design, so the entire experiment lasted about a year.
Ultimately, Dr. Lee reported, the designs produced by humans had a 99% likelihood of being superior to those of the earlier computer algorithms, whereas EteRNABot produced designs with a 95% probability of outdoing the earlier algorithms. “The quality of the community’s designs is so good that even if you generated thousands of designs with computer algorithms, you’d never find one as good as the community’s,” Mr. Lee said.
When the project began, players were asked to design RNA that folded into specific shapes selected by the Das lab. Due to technologic advances that now enable Dr. Das and his team to synthesize 1,000 design sequences monthly instead of the original 30, EteRNA has become an open research project to which researchers from labs around the world can submit design challenges.
Even though EteRNA players may not be scientifically trained, they nonetheless have instincts that, when reinforced by the lab experiments, can lead to new insights. “Most players didn’t have tactical insights on RNA designs,” Mr. Lee said. “They would just recognize patterns—visual patterns. Scientifically, not all of these rules initially seemed to make sense, but people who were following them did better.”
One design rule generated by the players involves “capping.” RNA consists of long sequences of pairs of nucleotides and typically the simplest way to create a sequence or “stack” that will not tear itself apart when synthesized is to fill it with guanine-cytosine (GC) pairs. However, too many GC pairs can generate some unforeseen shapes when synthesized, “It’s like doing origami with a cardboard box,” as one player noted.
According to Mr. Lee, the players found a solution by putting the GC pairs only at the end of the stack—capping—and filling the rest of the stack with adenine-uracil pairs. The investigators are now looking at expanding its design regimen to include three-dimensional (3D) designs. They also are developing a template that researchers in other fields can use to convert scientific projects into online challenges.
Related Links:
Carnegie Mellon University
Stanford University
EteRNA design challenge
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







